Document is current
Any future updates will be listed below
-
Authors
Edwards, Sarah J. L.
Aliu, Paul
Brierley, Joe
Holm, Søren
Pitts, Peter J.
-
Funding
Funding for this research was provided by:
AHRC IAA strategic award
- License Information
-
More Information
Article History
Received: 30 October 2024
Accepted: 15 February 2025
First Online: 10 April 2025
Declarations
:
: PA works for Novartis where he designs and implements early and expanded access schemes. PP worked for the FDA before founding the Centre for Medicines in the Public Interest, while SH, SE and JB receive consultancy from Clinigen to advise on the ethics of early access programmes.
